Answer
Gilteritinib fumarate (Gilteritinib Astellas) is indicated as monotherapy for adults with relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation.
Sources for this answer
- Gilteritinib Astellas 40 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked